GlassScriptPhysician profile
Austin Tran
NPI 1881262996
$1,320.12
in general payments reported to CMS, 2019-2025
9 companies · $946 in 2025
The $946 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2022: $68.22 · 2023: $61.95 · 2024: $122 · 2025: $946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,009 · Entertainment: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,009.13 |
| Entertainment | $120.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $311.40 | 2023-2025 | Misight Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $308.26 | 2025 | Xiidra, Miebo, Infuse Multifocal |
| Alcon Vision LLC | $220.57 | 2022-2025 | Wavelight Ex500 Excimer Laser |
| Tarsus Pharmaceuticals, INC. | $143.96 | 2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $121.84 | 2021 | |
| Optos, INC. | $120.93 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Glaukos Corporation | $60.86 | 2025 | Idosetr |
| Johnson & Johnson Vision Care, INC. | $17.54 | 2023 | Acuvue |
| Sun Pharmaceutical Industries INC. | $14.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.